Immunogenicity and Blocking Efficacy of Norovirus GII.4 Recombinant P Protein Vaccine

Noroviruses (NoVs) are the main cause of acute gastroenteritis in all ages worldwide. The aim of this study was to produce the recombinant P protein of norovirus and to demonstrate its blocking effect. In this study, the engineered strains were induced to express the P protein of NoVs GII.4, which w...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Zhendi Yu, Qingyi Shao, Zhangkai Xu, Chenghao Chen, Mingfan Li, Yi Jiang, Dongqing Cheng
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	MDPI AG 2023-06-01
סדרה:	Vaccines
נושאים:	norovirus recombinant P protein neutralizing antibody immunogenicity blocking efficacy
גישה מקוונת:	https://www.mdpi.com/2076-393X/11/6/1053
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!